Piper Sandler Reiterates Neutral Rating on STAAR Surgical (STAA) After 'A Number of Leadership Shifts'

March 18, 2025 10:27 AM EDT Send to a Friend
Piper Sandler analyst Matt O\'Brien reiterated a Neutral rating and $16.00 price target on STAAR Surgical (NASDAQ: STAA).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login